Skip to content

Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients With Chronic Obstructive Pulmonary Disease

Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06410547
Acronym
IMPL-AI-MENT
Enrollment
78
Registered
2024-05-13
Start date
2024-05-15
Completion date
2025-04-01
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

According to studies in the US and the Netherlands, 33-40% of patients with chronic conditions receive care that does not follow guideline recommendations. These findings have also been demonstrated in the management of COPD. This leads to under- or over-treatment of patients and, in the case of COPD, to exacerbations and hospitalisations. These exacerbations are a significant clinical problem, affecting patient's lung function, quality of life and mortality. They are also a burden on the healthcare system. Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management. In the past year, there have been remarkable innovations in the field of natural language processing, especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google. These models offer an opportunity to improve the implementation of evidence-based care in clinical practice. This study is a prospective, randomised trial that will compare therapy on discharge for patients with COPD. One arm will receive no intervention, while the other arm will receive a treatment recommendation from an LLM. The study will compare the percentage of patients treated according to the guideline.

Interventions

OTHERLLM

A LLM-based comparison between treatment and guideline.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of COPD * Consent * Discharge after hospitalization

Exclusion criteria

* Lack of Consent

Design outcomes

Primary

MeasureTime frameDescription
Adherence to treatment guidelines at the time of hospital dischargeFrom date of admission (which is enrollment) to the date of discharge, assessed up to one monthThe primary endpoint will assess whether the treatment at the time of discharge is consistent with the guidelines' recommendations. This is a binary outcome measure of yes or no.
Percentage of patients treated in concordance with treatment guidelines at the time of hospital dischargeFrom date of admission (which is enrollment) to the date of discharge, assessed up to one monthThis primary endpoint will assess the percentage of guideline-concordant treatments in each study arm.

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORMatthias Gröschel, MD PhD

Charité

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026